Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REVLIMID vs REVUMENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REVLIMID vs REVUMENIB: Safety Overview

Metric REVLIMID REVUMENIB
Total FAERS Reports 8,878 371
Deaths Reported 1,233 49
Death Rate 13.9% 13.2%
Hospitalizations 3,659 93
Average Patient Age 69.5 yrs 46.4 yrs
% Female Patients N/A 47.6%
FDA Approval Date N/A Nov 15, 2024
Manufacturer N/A Syndax Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status N/A Prescription